- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Square Pharmaceuticals Ltd (SQPH)
Square Pharmaceuticals Ltd stock price live, this page displays DH SQPH stock exchange data. View the SQPH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Square Pharmaceuticals Ltd real time stock price chart below.
What Is the Square Pharmaceuticals Ltd Stock Price Today?
The Square Pharmaceuticals Ltd stock price today is 220.00.
What Is the Stock Symbol for Square Pharmaceuticals Ltd?
The stock symbol for Square Pharmaceuticals Ltd is "SQPH."
What Stock Exchange Does Square Pharmaceuticals Ltd Trade On?
Square Pharmaceuticals Ltd is listed and trades on the DSE stock exchange.
Is Square Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Square Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SQPH quote. (ISIN: BD0473SQPH00)
What Is the Square Pharmaceuticals Ltd Stock Price Today?
The Square Pharmaceuticals Ltd stock price today is 220.00.
What Is the Stock Symbol for Square Pharmaceuticals Ltd?
The stock symbol for Square Pharmaceuticals Ltd is "SQPH."
What Stock Exchange Does Square Pharmaceuticals Ltd Trade On?
Square Pharmaceuticals Ltd is listed and trades on the DSE stock exchange.
Is Square Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Square Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SQPH quote. (ISIN: BD0473SQPH00)
DSE
Currency in BDT
220.00
+1.60(+0.73%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
218.40
220.50
52 wk Range
198.00
234.10
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
218.40220.50
52 wk Range
198.00234.10
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.45%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.45%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SQPH Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
351.47
Upside
+59.76%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 8 consecutive years
Square Pharmaceuticals Ltd Company Profile
Square Pharmaceuticals PLC., together with its subsidiaries, manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally. The company offers pharmaceutical products comprising alimentary preparations, amoebocides, analgesics, anthelmintics, anti-aphthous ulcer, anti-erectile dysfunction, anti-gout, anti-hyperkalemia, anti-osteoarthritis, anti-thyroid, anti-ulcerants, antiallergies, antianemics, antiasthma, antibiotics, antidiabetics, antifibrinolytics, antihemorrhoidals, antihistamines, antiosteoporotics, antioxidants, antiparasites, aromatase inhibitors, bone calcium regulators, erythropoiesis stimulating agents, gynae anti-infectives, magnesium, mineral supplements, non-narcotic analgesics, non-hormonals, non-steroidal anti-inflammatory drugs, anti-gout, antibacterials, vitamins, prolactin inhibitors, selective serotonin reuptake inhibitors, steroids, antifungals, antivirals, antiprotozoals, topical ear and nasal preparations, and urological preparations; and generic pharmaceuticals, infusions, lubricants, laxatives, and mouthwash. It also provides pharmaceuticals for cardiovascular, CNS, cough and cold, dialysis, digestive enzymes, eyes, hepatobiliary disorders, hyperphosphatemia, hypoactive sexual desire, inflammatory bowel, oncology, and respiratory tract infections. In addition, the company offers basic chemicals; herbal and nutraceutical; animal health; and crop care products, such as agricultural chemicals, insecticides, and pesticides; and reusable insulin pens under the AnsuPen brand. It exports its products to approximately 42 countries. The company was founded in 1958 and is headquartered in Dhaka, Bangladesh.
Compare SQPH to Peers and Sector
Metrics to compare | SQPH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSQPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 7.5x | 20.4x | −0.6x | |
PEG Ratio | 0.47 | −1.03 | 0.00 | |
Price/Book | 1.3x | 1.3x | 2.6x | |
Price / LTM Sales | 2.4x | 3.6x | 3.3x | |
Upside (Analyst Target) | 46.5% | 21.0% | 45.0% | |
Fair Value Upside | Unlock | 6.6% | 6.5% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 351.47
(+59.76% Upside)
Earnings
Latest Release
Nov 28, 2025
EPS / Forecast
8.35 / --
Revenue / Forecast
21.59B / --
People Also Watch
FAQ
What Is the Square Pharma (SQPH) Stock Price Today?
The Square Pharma stock price today is 220.00
What Stock Exchange Does Square Pharma Trade On?
Square Pharma is listed and trades on the Dhaka Stock Exchange.
What Is the Stock Symbol for Square Pharma?
The stock symbol for Square Pharma is "SQPH."
Does Square Pharma Pay Dividends? What’s The Current Dividend Yield?
The Square Pharma dividend yield is 5.45%.
What Is the Square Pharma Market Cap?
As of today, Square Pharma market cap is 193.60B.
What Is Square Pharma's Earnings Per Share (TTM)?
The Square Pharma EPS (TTM) is 29.27.
When Is the Next Square Pharma Earnings Date?
Square Pharma will release its next earnings report on Feb 25, 2026.
From a Technical Analysis Perspective, Is SQPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Square Pharma Stock Split?
Square Pharma has split 20 times.
How Many Employees Does Square Pharma Have?
Square Pharma has 15937 employees.
What is the current trading status of Square Pharma (SQPH)?
As of Feb 04, 2026, Square Pharma (SQPH) is trading at a price of 220.00, with a previous close of 220.10. The stock has fluctuated within a day range of 218.40 to 220.50, while its 52-week range spans from 198.00 to 234.10.
What Is Square Pharma (SQPH) Price Target According to Analysts?
The average 12-month price target for Square Pharma is BDT351.47, with a high estimate of BDT425 and a low estimate of BDT309.4. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +59.76% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.